West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:01:48 2026-08-27 pm EDT
|
5-day change | 1st Jan Change | ||
| 346.09 USD | -1.09% |
|
-2.17% | +25.79% |
| Aug. 26 | Boston Scientific hit by cyberattack, global operations affected | RE |
| Aug. 03 | Is everything under control? |  |
| Market Cap | 24.36B 20.91B 19.57B 17.92B 33.76B 2,326B 33.86B 232B 90.61B 1,172B 91.45B 89.47B 3,880B | P/E 2026 * |
40.4x | P/E 2027 * | 35.1x |
|---|---|---|---|---|---|
| Enterprise Value | 23.85B 20.48B 19.17B 17.55B 33.07B 2,278B 33.16B 227B 88.74B 1,148B 89.56B 87.62B 3,800B | EV / Sales 2026 * |
7.07x | EV / Sales 2027 * | 6.5x |
| Free-Float |
92.89% | Yield 2026 * |
0.26% | Yield 2027 * | 0.28% |
Last Transcript : West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | -1.09% | ||
| 1 week | -2.17% | ||
| Current month | +1.50% | ||
| 1 month | +4.48% | ||
| 3 months | +10.67% | ||
| 6 months | +36.07% | ||
| Current year | +25.79% |
| 1 week | 346.08 |  | 354.78 |
| 1 month | 330.69 | | 360.28 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 415.73 |
| 5 years | 187.43 | | 475.35 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 56 | 2015-04-23 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/11/26 | Fiscal year | Chief Financial Officer | 17,408 | 0.0247% | ||
| 6/30/26 | Other | Director | 46 | 0.0001% | ||
| 5/4/26 | Free | Director | 791 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.09% | -2.17% | +40.70% | -12.10% | 24.36B | |
| -2.20% | -2.23% | -15.11% | +7.08% | 193B | |
| -2.23% | -2.52% | -2.26% | +9.47% | 115B | |
| -2.00% | +2.08% | +10.56% | +78.98% | 61.3B | |
| -0.20% | -3.92% | +26.79% | +53.20% | 51.37B | |
| -1.09% | +0.27% | -3.72% | -32.81% | 51.24B | |
| +0.37% | -1.03% | +16.90% | -11.38% | 33.69B | |
| +0.20% | +6.35% | - | - | 30.4B | |
| -0.88% | +2.69% | -4.06% | +18.21% | 23.7B | |
| -1.60% | -1.18% | -6.43% | +2.90% | 22.71B | |
| Average | -1.07% | -0.17% | +7.04% | +12.62% | 60.7B | |
| Weighted average by Cap. | -1.54% | -1.01% | -0.05% | +14.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.37B 2.9B 2.71B 2.48B 4.68B 322B 4.69B 32.11B 12.55B 162B 12.67B 12.4B 538B | 3.59B 3.08B 2.88B 2.64B 4.97B 343B 4.99B 34.14B 13.34B 173B 13.47B 13.18B 571B |
| Net income | 615M 528M 494M 452M 852M 58.69B 854M 5.85B 2.29B 29.58B 2.31B 2.26B 97.9B | 701M 602M 564M 516M 972M 66.97B 975M 6.67B 2.61B 33.75B 2.63B 2.58B 112B |
| Net Debt | -503M -432M -404M -370M -698M -48.07B -700M -4.79B -1.87B -24.22B -1.89B -1.85B -80.18B | -1.04B -892M -835M -765M -1.44B -99.24B -1.44B -9.89B -3.87B -50.02B -3.9B -3.82B -166B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | $346.09 | -1.09% | 365,990 |
| 26-08-26 | $349.92 | +0.41% | 440,221 |
| 26-08-25 | $348.48 | -1.37% | 383,760 |
| 26-08-24 | $353.32 | +0.07% | 473,305 |
| 26-08-21 | $353.08 | -0.20% | 511,127 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
